We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
+37.44%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$2.19B
AUM Growth
+$107M
(+5.1%)
Cap. Flow
-$379M
Cap. Flow
% of AUM
-17.29%
Top 10 Holdings %
Top 10 Hldgs %
85.14%
Holding
39
New
9
Increased
2
Reduced
3
Closed
11
Top Buys
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$65M |
| 2 |
CG Oncology
CGON
|
+$31.9M |
| 3 |
ZBIO
Zenas BioPharma
ZBIO
|
+$26M |
| 4 |
Vaxcyte
PCVX
|
+$20.1M |
| 5 |
MREO
Mereo BioPharma
MREO
|
+$15M |
Top Sells
| 1 |
uniQure
QURE
|
+$233M |
| 2 |
Tango Therapeutics
TNGX
|
+$89.3M |
| 3 |
APLS
Apellis Pharmaceuticals
APLS
|
+$78M |
| 4 |
Xencor
XNCR
|
+$43.2M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
+$34.4M |
Sector Composition
| 1 | Healthcare | 99.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Zymeworks
ZYME
$1.81B
| $605M | 27.61% |
22,970,388
| – | – |
|
2
AnaptysBio
ANAB
$1.67B
| $382M | 17.44% |
7,880,094
| – | – |
|
3
Jazz Pharmaceuticals
JAZZ
$15.1B
| $290M | 13.24% |
1,706,469
| – | – |
|
4
Crinetics Pharmaceuticals
CRNX
$8.88B
| $200M | 9.11% |
4,288,120
| – | – |
|
|
CNTA
5
DELISTED
Centessa Pharmaceuticals
CNTA
| $77.9M | 3.56% |
3,115,000
+2,565,000
| +466% | +$65M |
|
6
CRISPR Therapeutics
CRSP
$4.99B
| $72.9M | 3.33% |
1,389,276
| – | – |
|
|
MBX
7
MBX Biosciences
MBX
$2.81B
| $67M | 3.06% |
2,123,604
| – | – |
|
8
Immunome
IMNM
$2.56B
| $61.3M | 2.8% |
2,855,590
-1,223,825
| -30% | -$21.5M |
|
9
Oric Pharmaceuticals
ORIC
$1.16B
| $55M | 2.51% |
6,728,116
| – | – |
|
|
LKFT
10
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $54.5M | 2.49% |
1,667,119
| – | – |
|
|
11
Xencor
XNCR
$1.11B
| $49.8M | 2.27% |
3,251,112
-2,893,655
| -47% | -$43.2M |
|
|
BBOT
12
BridgeBio Oncology
BBOT
$679M
| $35.3M | 1.61% |
2,823,126
| – | – |
|
13
Eton Pharmaceutcials
ETON
$1.05B
| $34.3M | 1.57% |
2,030,544
| – | – |
|
|
14
CG Oncology
CGON
$6.46B
| $32.1M | 1.46% |
+772,000
| New | +$31.9M |
|
|
ZBIO
15
Zenas BioPharma
ZBIO
$1.81B
| $28.7M | 1.31% |
+789,500
| New | +$26M |
|
16
Neurogene
NGNE
$787M
| $26.2M | 1.2% |
1,271,342
| – | – |
|
17
Structure Therapeutics
GPCR
$3.45B
| $23.3M | 1.06% |
+334,380
| New | +$13.7M |
|
|
18
Vaxcyte
PCVX
$8.12B
| $20.8M | 0.95% |
+450,000
| New | +$20.1M |
|
19
Aquestive Therapeutics
AQST
$494M
| $17M | 0.77% |
2,625,000
| – | – |
|
20
Voyager Therapeutics
VYGR
$192M
| $15.7M | 0.72% |
4,002,847
+3,332,544
| +497% | +$14.7M |
|
21
Atara Biotherapeutics
ATRA
$76.2M
| $10.4M | 0.47% |
573,183
| – | – |
|
22
MannKind Corp
MNKD
$1.25B
| $9.41M | 0.43% |
+1,660,000
| New | +$9.14M |
|
|
NUVB.WS
23
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
| $8.63M | 0.39% |
963,333
| – | – |
|
24
Evolus
EOLS
$390M
| $4.49M | 0.2% |
+675,000
| New | +$4.57M |
|
25
iBio
IBIO
$73.5M
| $4.3M | 0.2% |
+2,228,000
| New | +$3.04M |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM